Angiotensin (1-7)
low riskAlso: Ang(1-7) · MasR agonist · ACE2 product
Angiotensin (1-7) is the primary product of ACE2 enzymatic activity — the counter-regulatory arm of the renin-angiotensin system. Gained significant research attention post-COVID-19 (ACE2 is the SARS-CoV-2 receptor). Demonstrates cardiovascular protection, anti-fibrosis, and metabolic benefits in human trials.
Reported Benefits
Cardiovascular protection
Human trials show blood pressure reduction, endothelial improvement, and anti-fibrotic effects.
Mechanism of Action
Activates Mas receptor (MasR); opposes Angiotensin II/AT1R axis; produces vasodilation, natriuresis, anti-inflammatory, and anti-fibrotic effects.
ACE2 Pathway Context
Angiotensin (1-7) is the ‘good’ product of the renin-angiotensin system — opposing the pro-hypertensive, pro-fibrotic Angiotensin II. The COVID-19 pandemic dramatically increased research into ACE2/Ang(1-7) physiology.
✦ Sponsored
Stop Guessing About Your Health. Start Optimizing It.
Advanced diagnostics and licensed medical providers delivering personalized longevity care to uncover root causes, optimize health, and track progress virtually or in person.
Learn More →
Regulatory Status
Research OnlySafety Profile
Side Effects
- •Hypotension (dose-dependent)
- •Flushing
Contraindications
- •Severe hypotension
- •Pregnancy
Primary Uses
Related Peptides
Used For
Planning a protocol?
Use the AI Stack Builder to generate a phased schedule, compatibility analysis, and monitoring checklist.
Weekly Briefing
Regulatory updates + new study breakdowns.
For Practitioners
Do you prescribe Angiotensin (1-7)?
Get in front of patients who've already researched this protocol and are ready to consult. Featured listings from $199/mo.
Get Listed →